Literature DB >> 31366313

Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke.

Lorenzo Rinaldo1, Alejandro A Rabinstein2, Harry Cloft1,3, John M Knudsen3, Leonardo Rangel Castilla1,3, Waleed Brinjikji1,3.   

Abstract

Background and Purpose- Racial and ethnic disparities in the access to mechanical thrombectomy (MT) for treatment of acute ischemic stroke (AIS) secondary to large vessel occlusion have been previously described. The effect of recent randomized trials validating MT as an effective therapy for AIS secondary to large vessel occlusion on such disparities has not been investigated. Methods- Information on admissions for AIS to endovascular centers occurring between January 2016 and September 2018 was obtained from a national database. The number of patients receiving IV-tPA (intravenous tissue-type plasminogen activator) and MT at each institution was determined, and patient demographics were characterized according to age, sex, race/ethnicity, and insurance status. Comparisons of patients who did and did not undergo MT and between patients of different racial and ethnic backgrounds were performed. Demographic variables independently associated with the utilization of MT were identified using multivariate linear regression analysis. Results- There were 206 853 admissions to 173 endovascular centers during the time period of interest. The overall utilization of MT was 8.4%. The utilization of MT for black/Hispanic patients was lower than that among white/non-Hispanic patients (7.0% versus 9.8%; P<0.001). Black/Hispanic patients were also less likely to receive IV-tPA (16.2% versus 20.5%; P<0.001) and to be admitted to the endovascular center after transfer from a different hospital (20.0% versus 30.1%; P<0.001). On multivariate linear regression analysis, increasing institutional proportions of patients with female sex (β=-0.601; P<0.001), insurance with Medicaid or uninsured status (β=-0.153; P=0.029), and black/Hispanic race/ethnicity (β=-0.062; P=0.046) were independently associated with lower institutional utilization of MT. Conclusions- Despite the mainstream acceptance of MT for the treatment of AIS secondary to large vessel occlusion, racial and ethnic disparities in the utilization of MT persist.

Entities:  

Keywords:  Medicaid; insurance; patients; regression analysis; thrombectomy

Year:  2019        PMID: 31366313     DOI: 10.1161/STROKEAHA.118.024651

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  29 in total

1.  Letter by Willey and Williams Regarding Article, "Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke: Analysis of Data From 2016 to 2018".

Authors:  Joshua Z Willey; Olajide Williams
Journal:  Stroke       Date:  2019-10-14       Impact factor: 7.914

2.  Striving for Socioeconomic Equity in Ischemic Stroke Care: Imaging and Acute Treatment Utilization From a Comprehensive Stroke Center.

Authors:  Jason J Wang; Artem Boltyenkov; Jeffrey M Katz; Joseph O'Hara; Michele Gribko; Pina C Sanelli
Journal:  J Am Coll Radiol       Date:  2022-02       Impact factor: 5.532

3.  Health Equity: What the Neuroradiologist Needs to Know.

Authors:  J E Jordan; G B McGinty
Journal:  AJNR Am J Neuroradiol       Date:  2022-02-17       Impact factor: 3.825

4.  Disparities in the Use of Mechanical Thrombectomy Alone Compared with Adjunctive Intravenous Thrombolysis in Acute Ischemic Stroke in the United States.

Authors:  W Wahood; A A Rizvi; Y Alexander; M A Alvi; K R Rajjoub; H Cloft; A A Rabinstein; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-04       Impact factor: 3.825

Review 5.  Immune responses to stroke: mechanisms, modulation, and therapeutic potential.

Authors:  Costantino Iadecola; Marion S Buckwalter; Josef Anrather
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

6.  Interventions Targeting Racial/Ethnic Disparities in Stroke Prevention and Treatment.

Authors:  Deborah A Levine; Pamela W Duncan; Mai N Nguyen-Huynh; Olugbenga G Ogedegbe
Journal:  Stroke       Date:  2020-10-26       Impact factor: 7.914

7.  Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry.

Authors:  Hannah Gardener; Tatjana Rundek; Judith Lichtman; Erica Leifheit; Kefeng Wang; Negar Asdaghi; Jose G Romano; Ralph L Sacco
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-01-05       Impact factor: 2.136

8.  Underutilization of Endovascular Therapy in Black Patients With Ischemic Stroke: An Analysis of State and Nationwide Cohorts.

Authors:  Youngran Kim; Anjail Sharrief; Min Ji Kwak; Swapnil Khose; Rania Abdelkhaleq; Sergio Salazar-Marioni; Guo-Qiang Zhang; Sunil A Sheth
Journal:  Stroke       Date:  2022-01-24       Impact factor: 7.914

9.  Elevated post-ischemic ubiquitination results from suppression of deubiquitinase activity and not proteasome inhibition.

Authors:  Timo Kahles; Carrie Poon; Liping Qian; Victoria Palfini; Shanmukha Priya Srinivasan; Shilpa Swaminathan; Ismary Blanco; Reunet Rodney-Sandy; Costantino Iadecola; Ping Zhou; Karin Hochrainer
Journal:  Cell Mol Life Sci       Date:  2020-09-05       Impact factor: 9.261

10.  Inpatient palliative care utilization for patients with brain metastases.

Authors:  Meghan Price; Elizabeth P Howell; Tara Dalton; Luis Ramirez; Claire Howell; Theresa Williamson; Peter E Fecci; Carey K Anders; Devon K Check; Arif H Kamal; C Rory Goodwin
Journal:  Neurooncol Pract       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.